19.21

4.86% 0.89

After Hours: 19.20 -0.01 -0.05%

Adma Biologics Inc (ADMA)

Overview News Price History Option Chain Financials Discussions Forecast

Adma Biologics Inc stock is traded at $19.21, with a volume of 3.75M. It is up +4.86% in the last 24 hours and up +26.55% over the past month. ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Previous Close:

$18.32

Open:

$18.34

24h Volume:

3.75M

Relative Volume:

1.06

Market Cap:

$4.57B

Revenue:

$474.17M

Net Income/Loss:

$208.93M

P/E Ratio:

22.62

EPS:

0.8493

Net Cash Flow:

$65.61M

1W Performance:

+22.43%

1M Performance:

+26.55%

6M Performance:

-5.93%

1Y Performance:

-10.53%

1-Day Range:

$18.30

$19.22

1-Week Range:

$15.46

$19.22

52-Week Range:

$13.76

$25.67

Adma Biologics Inc Stock (ADMA) Company Profile

Name

Adma Biologics Inc

Sector

Healthcare (1134)

Industry

Biotechnology (635)

Phone

(201) 478-5552

Address

C/O ADMA BIOLOGICS, INC., RAMSEY

Employee

685

Twitter

@AdmaBiologics

Next Earnings Date

2025-03-03

Latest SEC Filings

ADMA's Discussions on Twitter

Compare ADMA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ADMA Adma Biologics Inc	19.21	4.36B	474.17M	208.93M	65.61M	0.8493
VRTX Vertex Pharmaceuticals Inc	429.82	107.58B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	787.32	80.03B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	429.80	57.37B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	917.93	55.83B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	209.02	44.13B	447.02M	-1.18B	-906.14M	-6.1812

Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-19-23	Resumed	Raymond James	Strong Buy
Oct-13-22	Initiated	Mizuho	Buy
Nov-11-21	Upgrade	Raymond James	Outperform → Strong Buy
Nov-09-21	Initiated	Cantor Fitzgerald	Overweight
Jun-04-19	Initiated	Jefferies	Buy
Apr-15-19	Reiterated	H.C. Wainwright	Buy
Feb-07-19	Resumed	H.C. Wainwright	Buy
Dec-11-17	Reiterated	Maxim Group	Buy
Nov-14-17	Upgrade	Raymond James	Mkt Perform → Outperform
Jan-23-17	Upgrade	Maxim Group	Hold → Buy
Aug-01-16	Downgrade	Maxim Group	Buy → Hold
Jul-25-16	Reiterated	Maxim Group	Buy
May-13-15	Reiterated	Maxim Group	Buy
Dec-08-14	Initiated	Oppenheimer	Outperform
Dec-01-14	Reiterated	Maxim Group	Buy

View All

Adma Biologics Inc Stock (ADMA) Latest News

Nov 25, 2025

Adma Biologics (ADMA) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Nov 25, 2025

Is ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Nov 25, 2025

Nov 24, 2025

What's Driving the Market Sentiment Around ADMA Biologics Inc? - Benzinga

Nov 24, 2025

High Growth Tech Stocks In The US For November 2025 - Yahoo Finance

Nov 24, 2025

Nov 23, 2025

Is ADMA Biologics Inc a good long term investmentBollinger Bands Signals & Access Free Tools and Start Investing - earlytimes.in

Nov 23, 2025

Nov 21, 2025

Adma Biologics (ADMA) CEO Grossman sells $336k in shares By Investing.com - Investing.com South Africa

Nov 21, 2025

Trading the Move, Not the Narrative: (ADMA) Edition - news.stocktradersdaily.com

Nov 21, 2025

Nov 20, 2025

ADMA Biologics: Why The Dip To $16 Resets The Buy Case (NASDAQ:ADMA) - Seeking Alpha

Nov 20, 2025

Why ADMA Biologics Inc. stock appeals to analysts2025 Price Targets & Risk Controlled Daily Plans - newser.com

Nov 20, 2025

Nov 19, 2025

Building trade automation scripts for ADMA Biologics Inc.Earnings Growth Summary & Daily Technical Forecast Reports - newser.com

Nov 19, 2025

Nov 17, 2025